In the morning of February 5, 2016, along with exciting atmosphere of a new spring all the country, DHG Pharma celebrated a "Closing ceremony 2015 and Employees conference 2016".

Attending the ceremony included Mr. Le Van Tam, a member of the city party standing committee and permanent Vice-president of Can Tho City People's Committee; Mrs. Bui Thi Le Phi - Director of Can Tho City Department of Health and representatives of the departments and unions of Can Tho City; Mr. Hoang Nguyen Hoc – the Board Chairman of DHG Pharma; Mrs. Pham Thi Viet Nga - CEO and Board of Management, staffs of the company.

The closing ceremony is an opportunity for the company employees together to look back on the results achieved during the year, as well as a sincere gratitude of the Board to individuals and collectives with outstanding achievements in their tasks for the development of the company. At the same time, awarding to individuals and collectives who completed successfully their tasks in 2015. In particular, collective emulation titles include 20 excellent groups, 35 advanced groups; Personal emulation titles: 1,567 advanced people, 183 emulation soldiers; 6 collectives and 35 individuals got Committee Merits; 35 collectives and 772 individuals were awarded by Department of Health; 10 collectives and 760 individuals were awarded by CEO DHG Pharma.

Here are some pictures recorded:


DHG Pharma honored to welcome the delegates to attend the conference



Deputy CEO Doan Dinh Duy Khuong summarized the work in 2015 and the orientation 2016


CHRO - Mrs. Tran Thi Anh Nhu summarized emulations and commendations of emulation titles 2015 (collectives and individuals) 

In 2015, DHG Pharma reached net sales VND3,609 billion; profit after tax VND594 billion. With these achievements, DHG Pharma honored one of the Top 10 pharmaceutical companies in Southeast Asia in terms of revenue, profit and market capitalization (according to Bloomberg and Statistics of DHG 2014); The only pharmaceutical company in Vietnam always in Top 10 leading Vietnamese Pharmaceutical Companies ranked by IMS Health.


CEO Pham Thi Viet Nga received a merit of Can Tho city People’s Committee that dedicated to DHG Pharma. 


CEO Pham Thi Viet Nga and Head of Investor Relations - Mrs. Le Thi Hong Nhung received Merits from the company Board of Directors 

Some pictures about excellent individuals and collectives in 2015 

The leader of Can Tho city People’s Committee expressed 


Chairman Hoang Nguyen Hoc expressed at the conference 

CEO Pham Thi Viet Nga replied to the leader of Can Tho city People’s Committee and the Board Chairman  

In order to maintain the leading position; consolidate and strengthen trust with customers, partners, and consumers; promote the trend "Vietnamese people use Vietnamese drugs" DHG Pharma continues to promote community activities to demonstrate social responsibility. In the spirit of solidarity, in 2015, DHG Pharma spent VND6 billion on the implementation of community programs such as organizing 138 programs for free exam and drugs for respectively 58,790 people in the provinces, cities and implementing 2 programs of free exam and drugs in Cambodia; sponsoring 6 cases of open heart surgery for patients in Binh Phuoc, An Giang, Soc Trang, Vinh Long, Can Tho and other meaningful activities.



Presidium of Employees Conference 2016

Mrs. Ong Thanh Kieu - President Trade Union reported summary of result of Employees Conference at the units


CEO Pham Thi Viet Nga and President Trade Union Ong Thanh Kieu signed a collective labor agreement of the company for the year 2016

Representatives of the sectors and the unions responded the emulation 


Representatives of the sectors and the unions responded the emulation.

The delegates reached an agreement with content of Conference Resolution 

CEO Pham Thi Viet Nga called the emulation 2016. 


All DHG Pharma staffs committed to fulfill the target 2016

DHG Pharma aims a target 2016 with net sales growth of over 15%/year; achieving 10% market share of generics production, increasing the number of research products and protection products (more 5 ones/year); increasing the proportion of use of natural materials in Vietnam; developing biotechnology products originated from nature and fulfilling social responsibility.